Orchestra BioMed Holdings, Inc. (OBIO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $426.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-81.00K; Retained Earnings (Accumulated Deficit)USD $-407.02M.
- 2026-03-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $424.50M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-40.00K; Retained Earnings (Accumulated Deficit)USD $-383.27M.
- 2025-12-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $416.08M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $60.00K; Retained Earnings (Accumulated Deficit)USD $-362.58M.
- 2025-09-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $412.51M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $45.00K; Retained Earnings (Accumulated Deficit)USD $-368.82M.
Orchestra BioMed Holdings, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00K | $426.42M | $-81.00K | $-407.02M | $19.32M | (m) | 3 month · $2.50M | (m) | (m) | (m) |
| 2026-03-31 | $6.00K | $424.50M | $-40.00K | $-383.27M | $41.19M | 3 month · $150.00K | 3 month · $2.85M | (m) | (m) | (m) |
| 2025-12-31 | $6.00K | $416.08M | $60.00K | $-362.58M | $53.57M | (m) | 12 month · $11.98M | 12 month · $3.48M | (m) | (m) |
| 2025-09-30 | $6.00K | $412.51M | $45.00K | $-368.82M | $43.74M | 3 month · $4.63M | 3 month · $3.01M | 3 month · $3.48M | (m) | (m) |
| 2025-06-30 | $4.00K | $348.27M | $16.00K | $-348.00M | $295.00K | (m) | 3 month · $3.25M | (m) | (m) | (m) |
| 2025-03-31 | $4.00K | $345.45M | $37.00K | $-328.63M | $16.86M | (m) | 3 month · $2.96M | (m) | (m) | (m) |
| 2024-12-31 | $4.00K | $342.78M | $52.00K | $-309.88M | $32.96M | 12 month · $465.00K | 12 month · $10.62M | (m) | (m) | (m) |
| 2024-09-30 | $4.00K | $339.84M | $98.00K | $-293.72M | $46.22M | 3 month · $465.00K | 3 month · $2.36M | (m) | (m) | (m) |
| 2024-06-30 | $4.00K | $322.44M | $-23.00K | $-278.30M | $44.12M | (m) | 3 month · $2.76M | (m) | (m) | (m) |
| 2024-03-31 | $4.00K | $319.51M | $-8.00K | $-262.32M | $57.19M | (m) | 3 month · $2.59M | (m) | (m) | (m) |
| 2023-12-31 | $4.00K | $316.90M | $-10.00K | $-248.85M | $68.04M | (m) | 12 month · $7.62M | (m) | (m) | (m) |
| 2023-09-30 | $4.00K | $315.76M | $-77.00K | $-236.04M | $79.66M | (m) | 3 month · $3.51M | (m) | (m) | (m) |
| 2023-06-30 | $4.00K | $312.25M | $-96.00K | $-222.72M | $89.44M | (m) | 3 month · $1.71M | (m) | (m) | (m) |
| 2023-03-31 | $3.00K | $310.46M | $-35.00K | $-210.67M | $99.75M | (m) | 3 month · $1.49M | (m) | $99.75M | (m) |
| 2022-12-31 | $2.00K | $252.27M | $-8.00K | $-199.73M | $52.53M | (m) | 12 month · $3.38M | (m) | $52.53M | 12 month · $506.00K |
| 2022-09-30 | $445.00 | (m) | (m) | $-6.07M | $61.43M | (m) | 3 month · $2.22M | (m) | $-6.07M | (m) |
| 2022-06-30 | $445.00 | (m) | (m) | $-5.25M | $69.51M | (m) | 3 month · $219.00K | (m) | $-5.25M | 3 month · $506.00K |
| 2022-03-31 | $445.00 | (m) | (m) | $-4.38M | $78.00K | (m) | 3 month · $70.00K | (m) | $78.00K | (m) |
| 2021-12-31 | $445.00 | (m) | (m) | $-3.94M | $-19.78M | (m) | (m) | (m) | $-19.78M | (m) |
| 2021-09-30 | $445.00 | (m) | (m) | $-3.85M | (m) | (m) | (m) | (m) | $-3.85M | (m) |
| 2021-06-30 | $533.00 | $5.37M | (m) | $-373.87K | (m) | (m) | (m) | (m) | $-3.76M | (m) |
| 2021-03-31 | $532.00 | $5.28M | (m) | $-281.54K | (m) | (m) | (m) | (m) | $-3.67M | (m) |
| 2020-12-31 | $445.00 | $5.17M | $-3.56M | $-3.56M | $-3.56M | (m) | (m) | (m) | $-3.56M | (m) |
| 2020-09-30 | $530.00 | $5.08M | (m) | $-81.43K | (m) | (m) | (m) | (m) | $-3.47M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $13.54K | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |